Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,695.11 -5.82 -0.22%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,231.26 +1.75 0.02%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:US

39.6400 USD 0.3200 0.81%

As of 20:04:06 ET on 06/18/2013.

Company Profile for Teva Pharmaceutical Industries Ltd (TEVA)

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Contact Information

Teva Pharmaceutical Industries Ltd

5 Basel Street
PO Box 3190
Petach Tikva
Israel
Phone: 972-3-914-8171
Fax: 972-3-914-8678

Key Executives for Teva Pharmaceutical Industries Ltd (TEVA)

Phillip FrostChairmanJeremy M LevinPresident/CEO
Allan ObermanPresident & CEO:AmericasRobert Koremans "Rob"President & CEO:Europe
Carlo De NotaristefaniPresident & CEO:Global OpsJudith VardiPresident & CEO:Emia & Asia Pacific
Michael R HaydenPres:Global R&D/Chief Scientific OfcrEyal DeshehGroup Exec VP/CFO
Richard S EgosiGroup Exec VP/Chief Legal Ofcr/SecyPaul J SekhriGroup Exec VP:Global/Chief Strategy Ofcr
Isaac Abravanel "Ica"Group Exec VP:Human ResourcesKevin C MannixVP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil